KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2025)

Vir Biotechnology (VIR) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.07 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 41.26% to 0.07 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07 through Dec 2025, up 41.26% year-over-year, with the annual reading at 0.06 for FY2025, 27.63% up from the prior year.
  • Asset Utilization Ratio hit 0.07 in Q4 2025 for Vir Biotechnology, up from 0.02 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q1 2022 to a low of 0.02 in Q2 2025.
  • Historically, Asset Utilization Ratio has averaged 0.26 across 5 years, with a median of 0.06 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: surged 1909.12% in 2022 and later plummeted 94.02% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.69 in 2021, then dropped by 10.11% to 0.62 in 2022, then crashed by 92.96% to 0.04 in 2023, then rose by 10.39% to 0.05 in 2024, then surged by 41.26% to 0.07 in 2025.
  • Business Quant data shows Asset Utilization Ratio for VIR at 0.07 in Q4 2025, 0.02 in Q3 2025, and 0.02 in Q2 2025.